Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.
Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.
Golde To Step Down At MSK; Porter Joins Hogan & Hartson.
FASEB Calls For 15% Increase For NIH Next Fiscal Year.
Holden Center At U. Of Iowa Designated Comprehensive.
Obit: George Santos, Hopkins Cancer Treatment Pioneer.
Course On Human Research Protections Goes Online @ Cancer.Gov.
FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.
NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.
US Oncology To Participate In Firm’s Ovarian Cancer Trial.
Atrix, Sanofi In Marketing Deal For Leuprogel Products.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
